| Company Name: | DuPont E.I. DE Nemours & Company | | Ticker Symbol: | DD | | | WWW Address: | www.dupont.com | | CEO: | Ellen J. Kullman | | No. of Employees: | 60,000 | | Common Issue Type: | CS | | Business Description: | The Company offers a range of innovative products and services for markets including agriculture and food, building and construction, electronics and communications, general industrial and transportation.
|
| | | Industry Information: | CHEMICALS - Chemicals - Major Diversified [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 34.76 |  0.25 | 31.5 | 35.35 | 34.79 | 35.27 | 34.60 | 4990684 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 31,412.6 | 903.7 | 1.41 | 2.20 | 1.64 | 45.7 | 4.7 | 35.35 - 16.05 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 34.76 | $ | | PE Ratio - LTM | 45.7 | |
| Market Capitalisation | 31,413.7 | mil |
| Latest Shares Outstanding | 903.7 | mil |
| Earnings pS (EPS) | 2.20 | $ |
| Dividend pS (DPS) | 1.64 | ¢ |
| Dividend Yield | 4.7 | % |
| Dividend Payout Ratio | 75 | % |
| Revenue per Employee | 508,817 | $ |
| Effective Tax Rate | 15.9 | % |
| Float | 901.1 | mil |
| Float as % of Shares Outstanding | 99.7 | % |
| Foreign Sales | 19,438 | mil |
| Domestic Sales | 11,091 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 13.30 | % |
| Research & Devlopment (R&D) as % of Revenue | 5.20 | % |
| Gross Profit Margin | 25.4 | % |
| EBITDA Margin | 6.9 | % |
| Pre-Tax Profit Margin | 2.6 | % |
| Assets Turnover | 0.7 | % |
| Return on Assets (ROA) | 1.9 | % |
| Return on Equity (ROE) | 9.2 | % |
| Return on Capital Invested (ROCI) | 4.5 | % |
| Current Ratio | 1.6 | |
| Leverage Ratio (Assets/Equity) | 4.9 | |
| Interest Cover | 2.6 | |
| Total Debt/Equity (Gearing Ratio) | 1.49 | |
| LT Debt/Total Capital | 50.0 | % |
| Working Capital pS | 6.41 | $ |
| Cash pS | 2.49 | $ |
| Book-Value pS | 8.20 | $ |
| Tangible Book-Value pS | 2.98 | $ |
| Cash Flow pS | 2.41 | $ |
| Free Cash Flow pS | 0.40 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 4.24 | |
| Price/Tangible Book Ratio | 11.68 | |
| Price/Cash Flow | 14.4 | |
| Price/Free Cash Flow | 85.8 | |
| P/E as % of Industry Group | 140.0 | % |
| P/E as % of Sector Segment | 66.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 10/21/2009 |
| Dividend Ex-Date | 11/09/2009 |
| Dividend Record Date | 11/12/2009 |
| Dividend Pay Date | 12/13/2009 |
| Dividend Amount | 410 |
| Type of Payment | Cash Payment |
| Dividend Rate | 1.64 |
| Current Dividend Yield | 4.7 |
| 5-Y Average Dividend Yield | 3.9 |
| Payout Ratio | 75.0 |
| 5-Y Average Payout Ratio | 63.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.7 | 99 | 60,639 | 49,323 |
| 4 Weeks | 35.35 | 31.64 | 31.82 | 9.2 | 102 | 64,101 | 1,025,624 |
| 13 Weeks | 35.35 | 30.06 | 32.56 | 6.8 | 99 | 67,586 | 4,055,184 |
| 26 Weeks | 35.35 | 23.91 | 28.47 | 22.1 | 101 | 73,656 | 9,133,402 |
| 52 Weeks | 35.35 | 16.05 | 25.06 | 38.7 | 112 | 84,068 | 20,848,983 |
| YTD | 35.35 | 16.05 | - | 37.4 | 112 | 83,147 | 18,791,209 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 34.88 | 34.54 | 33.22 | 30.35 | 28.22 | 1.41 | 1.45 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 0.66 | 4.1 | -0.40 |
| Income | -7.33 | 8.9 | -30.90 |
| Dividend | 3.27 | 93.1 | 3.63 |
| Capital Spending | -4.42 | NA | 10.01 |
| R&D | 0.39 | NA | 1.04 |
| Normalized Inc. | -11.15 | NA | -25.89 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -20.3 | -18.3 | 3.9 |
| Earnings % | -50.2 | 11.4 | -32.8 |
| EPS % | -50.2 | 12.5 | -31.7 |
| EPS $ | -1.45 | 0.05 | -1.02 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 15.47 |
| Current Ratio | 1.6 |
| Quick Ratio (Acid Test) | 0.9 |
| Liquidity Ratio (Cash) | 0.38 |
| Receivables Turnover | 5.6 |
| Average Collection Period | 64 |
| Working Capital/Equity | 81.3 |
| Working Capital pS | 6.21 |
| Cash-Flow pS | 3.81 |
| Free Cash-Flow pS | -0.54 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.02 |
| Financial Leverage Ratio (Assets/Equity) | 5.3 |
| Debt Ratio | 80.3 |
| Total Debt/Equity (Gearing Ratio) | 1.40 |
| LT Debt/Equity | 1.11 |
| LT Debt/Capital Invested | 131.2 |
| LT Debt/Total Liabilities | 26.3 |
| Interest Cover | 7.4 |
| Interest/Capital Invested | 1.42 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 13.80 |
| Tobin's Q Ratio | 0.87 |
| Current P/E Ratio - LTM | 45.70 |
| Enterprise Value (EV)/EBITDA | 19.64 |
| Enterprise Value (EV)/Free Cash Flow | -119.58 |
| Dividend Yield | 4.7 |
| Price/Tangible Book Ratio - LTM | 11.68 |
| Price/Book Ratio - LTM | 4.24 |
| Price/Cash Flow Ratio | 14.4 |
| Price/Free Cash Flow Ratio - LTM | 85.8 |
| Price/Sales Ratio | 1.23 |
| P/E Ratio (1 month ago) - LTM | 43.7 |
| P/E Ratio (26 weeks ago) - LTM | 19.9 |
| P/E Ratio (52 weeks ago) - LTM | 7.2 |
| 5-Y High P/E Ratio | 27.9 |
| 5-Y Low P/E Ratio | 9.7 |
| 5-Y Average P/E Ratio | 17.6 |
| Current P/E Ratio as % of 5-Y Average P/E | 260 |
| P/E as % of Industry Group | 140.0 |
| P/E as % of Sector Segment | 66.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 33.0 |
| PER SHARE FIGURES |
| LT Debt pS | 8.46 |
| Current Liabilities pS | 10.76 |
| Tangible Book Value pS - LTM | 2.98 |
| Book Value pS - LTM | 8.20 |
| Capital Invested pS | 16.34 |
| Cash pS - LTM | 2.49 |
| Cash Flow pS - LTM | 2.41 |
| Free Cash Flow pS - LTM | 0.40 |
| Earnings pS (EPS) | 2.20 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -1.60 |
| Free Cash Flow Margin 5YEAR AVG | 1.11 |
| Net Profit Margin | 6.6 |
| Net Profit Margin - 5YEAR AVRG. | 8.5 |
| Equity Productivity | 4.43 |
| Return on Equity (ROE) | 29.1 |
| Return on Equity (ROE) - 5YEAR AVRG. | 25.6 |
| Capital Invested Productivity | 2.07 |
| Return on Capital Invested (ROCI) | 13.6 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 15.0 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 5.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | 7.0 |
| Gross Profit Margin | 25.4 |
| Gross Profit Margin - 5YEAR AVRG. | 29.1 |
| EBITDA Margin - LTM | 6.9 |
| EBIT Margin - LTM | 4.2 |
| Pre-Tax Profit Margin | 7.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 10.2 |
| Effective Tax Rate | 15.9 |
| Effective Tax Rate - 5YEAR AVRG. | 12.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 148 |
| Revenue per Employee | 508,817 |
| Net Income per Employee | 33,450 |
| Average Collection Period | 61 |
| Receivables Turnover | 5.6 |
| Day's Inventory Turnover Ratio | 87 |
| Inventory Turnover | 4.1 |
| Inventory/Sales | 18.6 |
| Accounts Payble/Sales | 10.25 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 5.45 |
| Fixed Assets Turnover | 1.46 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 8.38 |
| Revenue per $ Plant | 2.74 |
| Revenue per $ Common Equity | 4.43 |
| Revenue per $ Capital Invested | 2.07 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 11.8 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 11.7 |
| Research & Devlopment (R&D) as % of Revenue | 4.6 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 4.6 |
|
|  
| | |  |  | |
| |